Description:
CDC researchers have characterized epitopes of
Bacillus anthracis Lethal Factor (LF), a critical component of the
B. anthracis lethal toxin. These epitopes may allow for development of therapeutics for the treatment or prevention of
B. anthracis infection. They may also allow screening for
B. anthracis LF in a sample and development of a peptide anthrax vaccine.